In vitro experiments by Lisztwan et al. demonstrated that adding the aromatase blocker letrozole to an inhibitor of the IGF-1 R pathway synergistically blocks the proliferation and induces apoptosis of breast cancer cells [22]. This evidence concerns the gene CYP19A1 and breast cancer.